Karuna Therapeutics KRTX
$ 329.83
0.0%
Annual report 2023
added 02-22-2024
Karuna Therapeutics Income Statement 2011-2024 | KRTX
Annual Income Statement Karuna Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
11.8 B | 6.07 B | 3.06 B | 3.3 B | 1.13 B | - | - | - | - | - | - | - | - |
Shares |
37 M | 31.6 M | 29.1 M | 26.4 M | 12 M | - | - | - | - | - | - | - | - |
Historical Prices |
319 | 192 | 105 | 125 | 87.3 | - | - | - | - | - | - | - | - |
Net Income |
-434 M | -276 M | -144 M | -68.6 M | -44 M | -17.5 M | -6.03 M | - | - | - | - | - | - |
Revenue |
654 K | 10.6 M | 37 M | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-495 M | -290 M | -144 M | -71.8 M | -45.4 M | -14.5 M | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-493 M | -289 M | -143 M | -71.7 M | -45.3 M | -14.5 M | -4.8 M | - | - | - | - | - | - |
Operating Expenses |
495 M | 300 M | 181 M | 71.8 M | 45.4 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
131 M | 76.1 M | 52.6 M | 28.4 M | 20.9 M | 2.97 M | 1.19 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Karuna Therapeutics
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
37.7 M | 37.5 M | 34.8 M | 34.5 M | 32.3 M | 29.9 M | 29.8 M | 29.8 M | 29.6 M | 29.5 M | 27.8 M | 27 M | 26.7 M | 26.2 M | 26 M | 26 M | 22.9 M | 104 K | 2.68 K | 12 | 5 | 12 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-119 M | -103 M | -97.6 M | - | -77 M | -64.9 M | -58.2 M | - | -50.9 M | -34.4 M | -30.5 M | - | -18.8 M | -17 M | -8.66 M | - | -9.04 M | -15.1 M | -12 M | - | -6.24 M | -539 K | -2.41 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | 654 K | - | 81 K | 5.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-136 M | -120 M | -109 M | - | -81 M | -65.1 M | -58.6 M | - | -51.2 M | -34.5 M | -30 M | - | -19.5 M | -17.8 M | -10.1 M | - | -9.9 M | -15.1 M | -11.6 M | - | -2.47 M | -2.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -109 M | - | -80.2 M | -64.5 M | -58.3 M | - | -50.9 M | -34.4 M | -29.9 M | - | -19.4 M | -17.8 M | -10 M | - | -9.86 M | -15 M | -11.6 M | - | -2.47 M | -2.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
136 M | 120 M | 110 M | - | 81.1 M | 70.3 M | 58.6 M | - | 51.2 M | 34.5 M | 30 M | - | 19.5 M | 17.8 M | 10.1 M | - | 9.9 M | 15.1 M | 11.6 M | - | 2.47 M | 2.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
32.3 M | 27.4 M | 24.3 M | - | 19.1 M | 17.8 M | 14.8 M | - | 12.4 M | 10.4 M | 9.78 M | - | 6.94 M | 7.01 M | 5.64 M | - | 4.1 M | 8.29 M | 4.61 M | - | 1.06 M | 256 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency